Company News: Johnson & Johnson (JNJ) quarterly earnings beat analysts’ estimate

Market news

16 July 2019

Company News: Johnson & Johnson (JNJ) quarterly earnings beat analysts’ estimate

Johnson & Johnson (JNJ) reported Q2 FY 2019 earnings of $2.58 per share (versus $2.10 in Q2 FY 2018), beating analysts’ consensus of $2.44.

The company’s quarterly revenues amounted to $20.562 bln (-1.3% y/y), generally in line with analysts’ consensus estimate of $20.388 bln.

The company also announced it continued to see FY 2019 EPS of $8.53-8.63 (versus analysts’ consensus estimate of $8.62) but raised FY 2019 revenues guidance to $80.8-81.6 bln from prior $80.4-81.2 bln (versus analysts’ consensus estimate of $81.27 bln).

JNJ rose to $135.95 (+0.92%) in pre-market trading.

UK wage growth hits fresh post-crisis high - ING

RBA's minutes provide no indication of cutting rates again in the near term - TDS

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.